Juan Pablo Ospina Botero
Assistant Professor of Clinical Neurology
Department: Neurology
Contact information
3400 Civic Center Boulevard
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
MD
Universidad de los Andes, 2017.
MD
Universidad de los Andes, 2017.
Post-Graduate Training
Postdoctoral Research Fellow, Emory University , 2017-2017.
Postdoctoral Research Fellow, Massachusetts General Hospital, 2018-2019.
Intern for Internal Medicine, University of Chicago/ Northshore University Health System, 2019-2020.
Neurology Resident, University of Chicago, 2020-2023.
Chief Resident, University of Chicago Neurology, 2022-2023.
Neuro-Oncology Fellow, Massachusetts General/ Brigham & Women's/ Dana-Farber Cancer Institute, 2023-2025.
Postdoctoral Research Fellow, Emory University , 2017-2017.
Postdoctoral Research Fellow, Massachusetts General Hospital, 2018-2019.
Intern for Internal Medicine, University of Chicago/ Northshore University Health System, 2019-2020.
Neurology Resident, University of Chicago, 2020-2023.
Chief Resident, University of Chicago Neurology, 2022-2023.
Neuro-Oncology Fellow, Massachusetts General/ Brigham & Women's/ Dana-Farber Cancer Institute, 2023-2025.
Certifications
Program in Clinical Effectiveness, Harvard T.H. Chan School of Public Health, Boston, MA, 2024.
Permanent linkProgram in Clinical Effectiveness, Harvard T.H. Chan School of Public Health, Boston, MA, 2024.
Selected Publications
Lanman TA, Youssef G, Huang R, Rahman R, DeSalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN: Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes Neurooncol Adv 7(1): vdae227, Dec 2024 Notes: doi: 10.1093/noajnl/vdae227.Ospina JP, Wen PY: Medical and neurologic management of brain tumor patients. Curr Opin Neurol 37(6): 657-665, Dec 2024 Notes: DOI: 10.1097/WCO.0000000000001315.
Fortunato J, Ospina JP, Park DM: Chordoma. Neuro-Oncology. MedLink Neurology. San Diego: MedLink LLC, Nov 2024 Notes: https://www.medlink.com/articles/chordoma. Contributor.
Ospina JP, Viera M, Wetzel E, Cahill D, Gerstner ER, Miller JJ: Impact of resection at time of first recurrence in WHO Grade 2 IDH-mutant gliomas. Society for NeuroOncology Annual Meeting 2024 Nov 2024 Notes: Poster Presentation.
Ospina JP, Boss S, Javed A: Tractrography for Evaluation of Clinical Weakness in a Patient with Pilocytic Astrocytoma. Chicago, IL Jun 2023 Notes: Poster presented at Arnason Symposium, University of Chicago.
Duque L, Ospina JP, Savica R, Philbrick K, Port JD, Singh B: Characterization of Brain FDGPET Findings in Patients with Catatonia: A Case Series. Boston, MA Mar 2023 Notes: Poster presented at the American Neuropsychiatric Association Meeting.
Ospina, JP, Park, DM: Craniopharyngioma Neuro-Oncology, MedLink Neurology. San Diego: MedLink LLC, Feb 20220 Notes: https://www.medlink.com/articles/craniopharyngioma. Contributor.
Duque L, Ospina JP, Philbrick K: Manic Episode as a Manifestation of Recurrent Primary Central Nervous System Lymphoma with Intravascular Involvement. Atlanta, GA Oct 2022 Notes: Poster presented at the Academy of Consultation-Liaison Psychiatry Annual Meeting.
Duque L, Ospina JP, Philbrick K, Singh B: Functional Neuroimaging in Patients with Catatonia: A Systematic Review. New Orleans, LA May 2022 Notes: Poster presented at the American Psychiatry Association Annual Meeting.
Duque L, Ospina JP, Singh B: Mixed Affective Episode as Initial Manifestation of Glioblastoma Multiforme. Cartagena, Colombia Feb 2022 Notes: Poster presented at the World Psychiatry Association – Latin America Regional Congress.